- Report
- August 2026
- 199 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 193 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 186 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 185 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 194 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 186 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 186 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 196 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 191 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 192 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 199 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 184 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 196 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 182 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 185 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 196 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 190 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 182 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 183 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 191 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP

The Genomic Medicine market is a rapidly growing sector of the genomics industry. It focuses on the development and application of genomic technologies to improve healthcare outcomes. This includes the use of genomic sequencing to diagnose and treat diseases, as well as the development of personalized treatments based on a patient's genetic profile. Genomic Medicine also involves the use of bioinformatics to analyze and interpret genomic data, and the development of new technologies to enable the use of genomic data in clinical practice.
The Genomic Medicine market is driven by the increasing availability of genomic data, advances in sequencing technologies, and the growing demand for personalized healthcare. It is expected to continue to grow in the coming years, as more healthcare providers adopt genomic technologies and the use of genomic data becomes more widespread.
Some companies in the Genomic Medicine market include Illumina, Thermo Fisher Scientific, BGI, and Pacific Biosciences. Show Less Read more